Deval L. Patrick, Director at Global Blood Therapeutics, Inc. (GBT), sold 54,106 shares at $29.69 ($1.6M) on 2017-07-25, disclosed to the SEC on 2017-07-27.
Open-market sale of $1.6M GBT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.69 | 27,053 | $803K | 50.0% |
| 2 | $29.69 | 27,053 | $803K | 50.0% |
| Total | $29.69 avg | 54,106 | $1.6M | 100% |
| Filing → |
| CERE | SELL | 2023-11-03 | $753K | — | Filing → |
| CERE | SELL | 2022-09-14 | $2.9M | — | Filing → |
| AMWL | BUY | 2022-04-22 | $198K | — | Filing → |